Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease

被引：0
|
作者：
Hassan Saadati
Hamid Reza Baradaran
Goodarz Danaei
Afshin Ostovar
Farzad Hadaegh
Leila Janani
Ewout W. Steyerberg
Davood Khalili
机构：
[1] Iran University of Medical Sciences,Department of Epidemiology, School of Public Health
[2] Medical Sciences and Nutrition University of Aberdeen,Ageing Clinical and Experimental Research Team, Institute of Applied Health Sciences, School of Medicine
[3] Iran University of Medical Sciences,Endocrine Research Center, Institute of Endocrinology and Metabolism
[4] Harvard TH Chan School of Public Health,Department of Global Health and Population and Department of Epidemiology
[5] Tehran University of Medical Sciences,Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute
[6] Research Institute for Endocrine Sciences,Prevention of Metabolic Disorders Research Center
[7] Shahid Beheshti University of Medical Sciences,Department of Biostatistics, School of Public Health
[8] Iran University of Medical Sciences,Department of Biomedical Data Sciences
[9] Leiden University Medical Center,Department of Public Health
[10] Erasmus MC,Department of Biostatistics and Epidemiology
[11] Research Institute for Endocrine Sciences,undefined
[12] Shahid Beheshti University of Medical Sciences,undefined
来源：
BMC Medical Informatics and Decision Making | / 20卷
关键词：
Preferences; Statins; Benefit harm outcomes; Primary prevention; Cardiovascular disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Cardiovascular Disease Risk-Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network
    Saeed, Anum
    Zhu, Jianhui
    Thoma, Floyd
    Marroquin, Oscar
    Aiyer, Aryan
    Agarwala, Anandita
    Virani, Salim S.
    Gulati, Martha
    Lee, Joon S.
    Reis, Steven
    Saba, Samir
    Ballantyne, Christie
    Mulukutla, Suresh
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2021, 14 (09): : E007485
  • [32] Predictors of Statin Initiation for Primary Prevention of Cardiovascular Disease in Familial Hypercholesterolemia Phenotype: A Veterans Health Administration Study
    Qazi, Saadia
    Tarko, Laura M.
    Ho, Yuk-Lam
    Orkaby, Ariela R.
    Sun, Yan, V
    Assimes, Themistocles L.
    Gagnon, David R.
    Cho, Kelly
    Djousse, Luc
    Gaziano, J. Michael
    O'Donnell, Christopher J.
    Wilson, Peter W.
    CIRCULATION, 2018, 138
  • [33] Costs and health effects of adding functional foods containing phytosterols/-stanols to statin therapy in the prevention of cardiovascular disease
    Eussen, Simone R. B. M.
    Feenstra, Talitha L.
    Toxopeus, Ido B.
    Hoekstra, Jeljer
    Klungel, Olaf H.
    Verhagen, Hans
    van Kranen, Henk J.
    Rompelberg, Cathy J. M.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 668 : S91 - S100
  • [34] Statin prescribing for prevention of cardiovascular disease amongst people with severe mental illness: Cohort study in UK primary care
    Blackburn, R.
    Osborn, D.
    Walters, K.
    Nazareth, I.
    Petersen, I.
    SCHIZOPHRENIA RESEARCH, 2018, 192 : 219 - 225
  • [35] Opioid substitution therapy clients' preferences for targeted versus general primary health-care outlets
    Islam, M. Mofizul
    Topp, Libby
    Conigrave, Katherine M.
    Day, Carolyn A.
    DRUG AND ALCOHOL REVIEW, 2013, 32 (02) : 211 - 214
  • [36] Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease
    Pandya, Ankur
    Sy, Stephen
    Cho, Sylvia
    Weinstein, Milton C.
    Gaziano, Thomas A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (02): : 142 - 150
  • [37] Clinical encounter length and initiation of statin therapy for primary prevention among adults with elevated atherosclerotic cardiovascular disease risk
    Zheutlin, Alexander R.
    Zhang, Mingyuan
    Conroy, Molly B.
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 13
  • [38] Implications of guidelines for statin treatment for primary prevention of cardiovascular disease - risk factor analysis of the Scottish Health Survey 2003
    Haq, I. U.
    Hill, J.
    Craig, J.
    Ritchie, L. D.
    EUROPEAN HEART JOURNAL, 2007, 28 : 210 - 211
  • [39] Randomized cluster trial of a public health intervention to enhance cardiovascular disease prevention in primary care
    Paradis, Gilles
    Renaud, L.
    Leaune, V.
    Chevalier, S.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2012, 22 : 218 - 218
  • [40] Chronic pain and cardiovascular disease prevention in primary care: a review of Australian primary health network needs assessments
    Walker, Pippy
    Cornell, Samuel
    De Morgan, Simone
    Bonner, Carissa
    Blyth, Fiona M.
    AUSTRALIAN HEALTH REVIEW, 2022, 46 (01) : 70 - 77
12345